Tag: Celltrion USA

Celltrion USA announces availability of adalimumab-aaty with 85% discount

businessnewstoday- May 10, 2024

In a bold move to reshape the pharmaceutical landscape, Celltrion USA has announced the availability of its high-concentration, citrate-free biosimilar adalimumab-aaty, under the brand name ... Read More

Celltrion USA launches ZYMFENTRA for ulcerative colitis and Crohn’s disease

businessnewstoday- March 18, 2024

In a significant advancement for patients with digestive disorders, Celltrion USA has announced the availability of ZYMFENTRA (infliximab-dyyb), marking it as the first and only ... Read More